ISRCTN45877994
Completed
未知
Early Surgery versus optimal Current step-up prActice for chronic PancrEatitis (ESCAPE): a multi-centre randomised controlled trial
Academic Medical Centre Amsterdam (Netherlands)0 sites88 target enrollmentMarch 25, 2011
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Chronic pancreatitis
- Sponsor
- Academic Medical Centre Amsterdam (Netherlands)
- Enrollment
- 88
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
2013 protocol in: http://www.ncbi.nlm.nih.gov/pubmed/23506415 2020 results in: https://www.ncbi.nlm.nih.gov/pubmed/31961419 (added 22/01/2020)
Investigators
Eligibility Criteria
Inclusion Criteria
- •Registration criteria:
- •1\. Age 18 years
- •2\. Confirmed chronic pancreatitis: according to the M\-ANNHEIM diagnostic criteria
- •3\. Dilated pancreatic duct \[5 mm, established by magnetic resonance cholangiopancreatography (MRCP), Computerised Tomography (CT) or Endoscopic ultrasound (EUS)], with or without enlargement of the pancreatic head
- •4\. Presence of moderate, non\-debilitating pain. This will be defined as chronic abdominal pain (present for at least 3 months) sufficiently relieved with non\-opioid analgesics
- •Randomisation criteria (after fulfilling inclusion criteria for registration):
- •1\. Need for upgrade from non\-opioids to opioid analgesics: newly developed need for opioids analgesics (opioids needed at least 3 days per week) and persistently needed for at least 2 weeks in a row
- •2\. Informed consent for randomisation
Exclusion Criteria
- •1\. History of prolonged need of opioids for chronic pancreatitis for a period over 2 months in the last 2 years
- •2\. Previous pancreatic surgery
- •3\. Previous endoscopic dilatation or stenting of the pancreatic duct
- •4\. Episode of biliary obstruction in the last 2 months (defined as jaundice or bilirubine levels 25 micromol / L) or the presence of a stent in the common bile duct (CBD)
- •5\. Proven autoimmune pancreatitis (including elevated levels of gamma\-globulins (IgG))
- •6\. Suspected or established pancreatic malignancies
- •7\. Life expectancy of \< 1 year for any reason
- •8\. Presence of duodenal obstruction necessitating surgery, as judged by the expert panel
- •9\. Presence of a pseudocyst larger than 6 cm necessitating intervention, as judged by the expert panel
- •10\. Contra\-indications for surgery, always evaluated by the expert panel (e.g. American Society of Anesthesiology class IV, severe portal hypertension due to occluded portal vein)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Early Surgery versus optimal Current step-up prActice for chronic PancrEatitis.Chronic pancreatitisNL-OMON27341Academic Medical Center AmsterdamDepartment of Surgery PO Box 22660, 1100 DD AmsterdamTel: +31205662666Fax: +3120566924388
Completed
Not Applicable
Early Surgery versus optimal Current step-up prActice for chronic PancrEatitis: ESCAPEchronic pancreatitis1001796910017998NL-OMON38261Academisch Medisch Centrum88
Completed
Not Applicable
Early Surgery Versus Conventional Treatment in Very Severe Aortic StenosisAortic StenosisNCT01161732Asan Medical Center145
Not yet recruiting
Not Applicable
A trial to compare pain in patients with chronic pancreatitis undergoing early versus late surgery.Health Condition 1: K860- Alcohol-induced chronic pancreatitisCTRI/2023/05/052196Department of surgical gastroenterology.
Terminated
Not Applicable
Stroke-free Survival Comparison Between Early Surgery and Conventional Therapy in Left Infective EndocarditisEndocarditisNCT03411499Maria Vittoria Hospital6